FDA Grants Complete Approval To Moderna's COVID-19 Vaccine For Children As Young As 6 Months

benzinga.com/news/fda/25/07/46351929/fda-grants-complete-approval-to-modernas-covid-19-vaccine-for-children-as-young-as-6-months

The U.S. Food and Drug Administration (FDA) has approved Moderna Inc.’s (NASDAQ:MRNA) supplemental Biologics License Application (sBLA) for Spikevax, the company’s COVID-19 vaccine, in children six months through 11 years of age who are at increased risk for COVID-19 disease.
The…

This story appeared on benzinga.com, 2025-07-10 18:13:59.
The Entire Business World on a Single Page. Free to Use →